pharmacology 3.2A sulfonamides, trimethoprim, quinolones Flashcards
Sulfacytine
Sulfisoxazole
Sulfamethizole
Sulfonamide
Oral, absorbable
Short-acting
Sulfonamide
Inhibits dihydropteroate synthetase
Inhibits folic acid synthesis
Inhibits both by competing with PABA
Sulfadiazine
Sulfamethoxazole
Sulfapyridine
Sulfonamide
Oral, absorbable
Intermediate-acting
Sulfadoxine
Sulfonamide
Oral, absorbable
Long-acting
Sulfasalazine
Sulfonamide
Oral, non-absorbable
Sodium sulfacetamide
Mafenide acetate
Silver sulfadiazine
Sulfonamide
Topical
Mafenide acetate
Sulfonamide
Topical
High toxicity (silver sulfadiazine is preferred)
Sulfonamide
Contraindicated in:
G6PD deficiency (hemoglobinemia)
Near term pregnancy -> Kernicterus (high bilirubin I)
Oral anti-coagulants
Trimethoprim
Inhibits tetrahydrofolate synthesis
By acting on the enzyme dihydrofolate reductase
For lower forms of organisms
Intermediate-acting (11hours)
Pyrimethamine
Inhibits tetrahydrofolate synthesis
By acting on dihydrofolate reductase
For higher forms of organisms (protozoans, parasites)
Long-acting
Sequential synergistic blockade
Blockade that causes decreased emergence of resistance due to synergistic activity of combined drugs
1:5
T:S
1:20
T:S peak
Trimethoprim and Pyrimethamine ADRs
ADR:
Megaloblastic anemia
Leucopenia
Granulocytopenia
Cotrimoxazole (Bactrim)
Trimethoprim-sulfamethoxazole
P. jiroveci causes pneumocystis in HIV/AIDS patients
Sulfadiazine+pyrimethamine+folinic acid
Protozoan toxoplasmosis
Backup Tx for leishmaniasis
Sulfadoxine+pyrimethamine (fansidar)
Malaria prophylaxis
Sulfasalazine
Ulcerative colitis
Oral non-absorbable enteritis
Inflammatory bowel disease
Mafenide acetate
Silver sulfadiazine
Burn wounds